Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Highly active antiretroviral therapy inhibits cytokine production in HIV-uninfected subjects.

× No keyword cloud information.

7 in total

1. Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis.

Authors: Rasheed Ahmad; Sardar T A Sindhu; Emil Toma; Richard Morisset; Ali Ahmad
Journal: J Virol Date: 2002-12 Impact factor: 5.103

2. HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos.

Authors: André Luis Souza Dos Santos
Journal: World J Biol Chem Date: 2010-02-26

3. Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation.

Authors: Ozlem Equils; Alan Shapiro; Zeynep Madak; Chunren Liu; Daning Lu
Journal: Antimicrob Agents Chemother Date: 2004-10 Impact factor: 5.191

Review 4. A 20-year history of childhood HIV-associated nephropathy.

Authors: Patricio E Ray; Lian Xu; Tamara Rakusan; Xue-Hui Liu
Journal: Pediatr Nephrol Date: 2004-08-05 Impact factor: 3.714

5. Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.

Authors: S A Stranford; J C Ong; B Martinez-Marino; M Busch; F M Hecht; J Kahn; J A Levy
Journal: Proc Natl Acad Sci U S A Date: 2001-01-02 Impact factor: 11.205

6. Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt's lymphoma and Kaposi's sarcoma.

Authors: Seong Eun Kim; Younggon Jung; Tae Hoon Oh; Uh Jin Kim; Seung-Ji Kang; Hee-Chang Jang; Kyung-Hwa Park; Kyung-Hwa Lee; Sook In Jung
Journal: BMC Cancer Date: 2018-11-08 Impact factor: 4.430

7. Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir.

Authors: Aline Grigorian; Rosemary Hurford; Ying Chao; Christina Patrick; T Dianne Langford
Journal: BMC Neurosci Date: 2008-02-26 Impact factor: 3.288

7 in total